Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04201600 · ClinicalTrials.gov registry record
Glucose Variability and Cognition in Prediabetes
A clinical trial of Depression and Aging, sponsored by University of Maryland, Baltimore.
- Recruiting
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT04201600: Recruiting study of Depression and Aging, sponsored by University of Maryland, Baltimore.
NCT04201600 is a study of Depression and Aging that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 30 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04201600, a study of Depression and Aging, is actively recruiting participants, sponsored by University of Maryland, Baltimore.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examines the association of variability in glucose values over a 10-day period with cognitive function and functional status among individuals with prediabetes, aged 50 or older.
Primary Outcome
Scores on the following standard neurocognitive tests will be z-transformed based on their respective means and standard deviations and combined into one aggregate total score such that higher values mean better executive functioning: Trails Making A and B, The Stroop-Color Word Test, Digit Span subscale of the Wechsler Adult Intelligence Scale - Revised (WAIS-IV), Digit Symbol Substitution Test (DSST)
Conditions Studied
Interventions
- DEVICE Continuous Glucose Monitoring System (CGMS)
Study Locations (1)
Maryland
- Baltimore VA Geriatric Research Education and Clinical Center (GRECC) - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2026-12-31 |
What NCT04201600 shows while recruiting
NCT04201600 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (96% lower).
The record links to 6 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Continuous Glucose Monitoring System (CGMS) is the first listed.
NCT04201600 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT04201600 about?
NCT04201600 is a clinical study titled "Glucose Variability and Cognition in Prediabetes". This study examines the association of variability in glucose values over a 10-day period with cognitive function and functional status among individuals with prediabetes, aged 50 or older.
What is the current status of trial NCT04201600?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2022-03-01. Estimated completion is 2026-12-31.
What conditions does trial NCT04201600 study?
This clinical trial studies the following conditions: Depression, Aging, PreDiabetes, Cognitive Decline, Glucose Metabolism Disorders (Including Diabetes Mellitus).
What interventions are being tested in trial NCT04201600?
The interventions under investigation include: Continuous Glucose Monitoring System (CGMS) (DEVICE).
Who is sponsoring clinical trial NCT04201600?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04201600 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04201600's enrollment target sits among peer trials
30 557th of 679 higher than 105 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Depression and Driving
RECRUITING
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy